Wirk B, Lim J. Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma. J Hematol [Internet]. 2025 Jun. 5 [cited 2025 Jun. 17];14(3):146-51. Available from: https://jh.elmerpub.com/jh/article/view/2046